Evidence map›Paper›PMID 30718725›Full record

ArticleScientific reports2019

Tuberculosis-associated anemia is linked to a distinct inflammatory profile that persists after initiation of antitubercular therapy.

Leonardo Gil-Santana, Luís A B Cruz, María B Arriaga, Pryscila F C Miranda, Kiyoshi F Fukutani, Paulo S Silveira-Mattos, Elisangela C Silva, Marina G Oliveira, Eliene D D Mesquita, Anneloek Rauwerdink and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Role of Iron Indices in Anemia in Patients With Pulmonary Tuberculosis.Interdisciplinary perspectives on infectious diseases · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Leonardo Gil-SantanaInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Luís A B CruzInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
María B ArriagaInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Pryscila F C MirandaTuberculosis Academic Program, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Kiyoshi F FukutaniInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.ORCID 0000-0003-2223-0918
Paulo S Silveira-MattosInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Elisangela C SilvaTuberculosis Academic Program, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Marina G OliveiraTuberculosis Academic Program, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Eliene D D MesquitaAry Parreira Institute, State Secretary of Health of Rio de Janeiro, Rio de Janeiro, Brazil.
Anneloek RauwerdinkAmsterdam Institute for Global Health and Development, Amsterdam University Academic Medical Centre, Amsterdam, The Netherlands.
Frank CobelensAmsterdam Institute for Global Health and Development, Amsterdam University Academic Medical Centre, Amsterdam, The Netherlands.
Martha M OliveiraCentro de Desenvolvimento Tecnológico em Saúde (CDTS), Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Afranio KritskiTuberculosis Academic Program, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Bruno B AndradeInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil. Bruno.andrade@bahia.fiocruz.br.ORCID 0000-0001-6833-3811
Universidade Federal do Rio de Janeiro · BRAmsterdam Institute for Global Health and Development · NLFaculdade de Tecnologia e Ciências · BRFundação Oswaldo Cruz · BRFundação de Amparo à Pesquisa do Estado da Bahia · BRUniversidade Salvador · BR

Funding

Inflammatory determinants of disease severity and treatment outcome in TB patientsU01AI115940 · NIAID · UNIVERSITY OF CAPE TOWN · PI SHER, ALAN, WILKINSON, ROBERT JOHN · 2015 to 2019
$1.1M
NIAID NIH HHS U01 AI115940
6 · The paper itself

Abstract

Pulmonary tuberculosis (PTB) is associated with chronic inflammation and anemia. How anemia impacts systemic inflammation in PTB patients undergoing antitubercular therapy (ATT) is not fully understood. In the present study, data on several blood biochemical parameters were retrospectively analyzed from 118 PTB patients during the first 60 days of ATT. Multidimensional statistical analyses were employed to perform detailed inflammatory profiling of patients stratified by anemia status prior to treatment. Anemia was defined as hemoglobin levels <12.5 g/dL for female and <13.5 g/dL for male individuals. The findings revealed that most of anemia cases were likely caused by chronic inflammation. A distinct biosignature related to anemia was detected, defined by increased values of uric acid, C-reactive protein, and erythrocyte sedimentation rate. Importantly, anemic patients sustained increased levels of several biochemical markers at day 60 of therapy. Preliminary analysis failed to demonstrate association between persistent inflammation during ATT with frequency of positive sputum cultures at day 60. Thus, TB patients with anemia exhibit a distinct inflammatory profile, which is only partially reverted at day 60 of ATT.

Indexed as

AdultAnemiaAntitubercular AgentsFemaleHumansInflammationMaleMiddle AgedStatistics, NonparametricTuberculosisYoung AdultAntitubercular Agents

Identifiers

PMID30718725
PMCPMC6361962
OpenAlexW2920591314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.